NYSE ARCA | ETF
The fund generally will invest at least 90% of its total assets in securities that comprise the underlying index.
The underlying index was composed of common stocks ofU. S. biotechnology and genome companies.
These companies are engaged principally in the research, development, manufacture and marketing and distribution of various biotechnological products, services and processes, etc.
It is non-diversified.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| ALNY | Alnylam Pharmaceuticals Inc | Healthcare | Biotechnology | 7.27% |
| NTRA | Natera Inc | Healthcare | Diagnostics & Research | 5.40% |
| BIIB | Biogen Inc | Healthcare | Drug Manufacturers - General | 5.27% |
| VRTX | Vertex Pharmaceuticals Inc | Healthcare | Biotechnology | 5.02% |
| INCY | Incyte Corporation | Healthcare | Biotechnology | 4.91% |
| AMGN | Amgen Inc | Healthcare | Drug Manufacturers - General | 4.83% |
| GILD | Gilead Sciences Inc | Healthcare | Drug Manufacturers - General | 4.82% |
| IMGN | ImmunoGen Inc | Healthcare | Biotechnology | 4.78% |
| RPRX | Royalty Pharma Plc | Healthcare | Biotechnology | 4.75% |
| REGN | Regeneron Pharmaceuticals Inc | Healthcare | Biotechnology | 4.70% |
| ILMN | Illumina Inc | Healthcare | Diagnostics & Research | 4.64% |
| IONS | Ionis Pharmaceuticals Inc | Healthcare | Biotechnology | 4.22% |
| UTHR | United Therapeutics Corporation | Healthcare | Drug Manufacturers - Specialty & Generic | 3.81% |
| AXSM | Axsome Therapeutics Inc | Healthcare | Biotechnology | 3.73% |
| ARWR | Arrowhead Pharmaceuticals Inc | Healthcare | Biotechnology | 3.69% |
| MNKD | MannKind Corp | Healthcare | Biotechnology | 3.58% |
| PTCT | PTC Therapeutics Inc | Healthcare | Biotechnology | 3.34% |
| BPMC | Blueprint Medicines Corp | Healthcare | Biotechnology | 3.32% |
| SRPT | Sarepta Therapeutics Inc | Healthcare | Biotechnology | 3.27% |
| EXAS | EXACT Sciences Corporation | Healthcare | Diagnostics & Research | 3.23% |